(141 days)
No
The document describes standard radiation therapy planning software functionalities and does not mention AI or ML.
No.
The device is planning software used to assist in formulating a treatment plan; it does not directly treat or diagnose a disease.
No
This device is a radiation therapy treatment planning software, assisting clinicians in formulating and evaluating treatment plans. It is not used to diagnose a medical condition but rather to plan its treatment.
No
The device description explicitly states that the system is composed of a Sun Unix workstation running the Solaris operating system and software, indicating it includes hardware components (the workstation).
Based on the provided information, the Pinnacle3 Radiation Therapy Planning Software is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens derived from the human body in order to provide information for diagnostic, monitoring or compatibility purposes. This typically involves analyzing biological samples like blood, urine, or tissue.
- Pinnacle3's Function: The description clearly states that Pinnacle3 is a computer software package used for radiation therapy treatment planning. It assists clinicians in formulating treatment plans based on patient data (likely including medical images) to deliver radiation to a target volume while minimizing dose to surrounding tissues.
- Lack of Biological Sample Analysis: There is no mention of the software analyzing biological specimens or providing diagnostic information based on such analysis. Its purpose is to plan a physical treatment (radiation delivery).
Therefore, Pinnacle3 falls under the category of a medical device used for treatment planning, but not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Pinnacle3™ Radiation Therapy Planning Software is a computer software package intended to provide support for radiation therapy treatment planning for the treatment of benign or malignant disease processes.
Pinnacle3 Radiation Therapy Planning Software assists the clinician in formulating a treatment plan that maximizes the dose to the treatment volume while minimizing the dose to the surrounding normal tissues.
The device is indicated for use in patients deemed to be acceptable candidates for radiation treatment in the judgment of the clinician responsible for patient care.
Plans generated using this software are used in the determination of the course of a patient's radiation treatment. They are to be evaluated, modified and implemented by qualified medical personnel.
Product codes (comma separated list FDA assigned to the subject device)
90 MUJ
Device Description
Pinnacle Radiation Treatment Planning Software is a system composed of a Sun Unix workstation running the Solaris operating system and software which provides the user with the capability to enter patient data into the system, use that data to construct a plan for radiation therapy, and evaluate the plan.
The system consists of a number of functional areas: physics, image import, image manipulation, contouring, point definition, photon and electron external beam treatment planning, stereotactic radiosurgery, brachytherapy, plan evaluation, file management and connectivity. Photons, electrons, stereotactic radiosurgery and brachytherapy functions are sold as separate options and may or may not be included in every system.
Pinnacle assists the clinician in formulating a treatment plan that maximizes the dose to the treatment volume while minimizing the dose to the surrounding normal tissues. Plans generated using this software are used in the determination of the course of a patient's radiation treatment. They are to be evaluated, modified and implemented by qualified medical personnel.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Qualified medical personnel
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical Tests:
Verification and Validation testing were completed in compliance with ADAC Laboratories procedures to demonstrate that the Pinnacle Radiation Therapy Planning Software has met all its specifications, demonstrates substantially equivalent performance to its predicate devices, and is safe and effective for its intended use.
Clinical Tests:
Clinical testing was not performed as part of the development of the device features described in this 510(k). Clinical testing is not required to demonstrate substantial equivalence or safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Pinnacle3 Apex Treatment Planning System, K951518, ADAC Pinnacle3 Software, K926008, ACQPlan System, K974770
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
MMS TherPac PLUS (K982821), I.M.S. Dose Calc. 1.02 (K990833)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.5050 Medical charged-particle radiation therapy system.
(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
APR - 7 2000
510(k) SUMMARY
| Device trade name: | Pinnacle3™ Radiation Therapy Planning Software |
|---|---|
| Common name: | Radiation Therapy Planning System |
| Classification name: | Accelerator, Linear, Medical (per 21CFR section |
| 892.5050) | |
| Predicate Devices: | Pinnacle3 Apex Treatment Planning System, K951518 |
| ADAC Pinnacle3 Software, K926008 | |
| ACQPlan System, K974770 |
Device Description:
Pinnacle Radiation Treatment Planning Software is a system composed of a Sun Unix workstation running the Solaris operating system and software which provides the user with the capability to enter patient data into the system, use that data to construct a plan for radiation therapy, and evaluate the plan.
The system consists of a number of functional areas: physics, image import, image manipulation, contouring, point definition, photon and electron external beam treatment planning, stereotactic radiosurgery, brachytherapy, plan evaluation, file management and connectivity. Photons, electrons, stereotactic radiosurgery and brachytherapy functions are sold as separate options and may or may not be included in every system.
Pinnacle assists the clinician in formulating a treatment plan that maximizes the dose to the treatment volume while minimizing the dose to the surrounding normal tissues. Plans generated using this software are used in the determination of the course of a patient's radiation treatment. They are to be evaluated, modified and implemented by qualified medical personnel.
Intended Use:
Pinnacle3 Radiation Therapy Planning System provides three-dimensional planning software for external beam (photons and electrons), stereotactic radiosurgery and brachytherapy planning.
Summary of Technological Characteristics Compared to Predicate Devices:
Pinnacle Radiation Therapy Planning Software has been designed to add new features and functions to the existing Pinnacle Apex Treatment Planning System, cleared under K951518, in 1995. Pinnacle Radiation Therapy Planning Software incorporates no technological characteristics not currently contained in the predicate devices, Pinnacle Apex System (K951518), ADAC Pinnacle Software (K926008S2),
000030
1
ACQPlan 3D RTP System (K974770), MMS TherPac PLUS (K982821), and I.M.S. Dose Calc. 1.02 (K990833).
Summary of Non-clinical Tests
Verification and Validation testing were completed in compliance with ADAC Laboratories procedures to demonstrate that the Pinnacle Radiation Therapy Planning Software has met all its specifications, demonstrates substantially equivalent performance to its predicate devices, and is safe and effective for its intended use.
Summary of Clinical Tests
Clinical testing was not performed as part of the development of the device features described in this 510(k). Clinical testing is not required to demonstrate substantial equivalence or safety and effectiveness.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around the perimeter. Inside the circle is a stylized image of three human figures, possibly representing health, hope, and service. The figures are connected and appear to be reaching upwards.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR - 7 2000
Janice E. Brown Corporate Director, Regulatory Affairs ADAC Laboratories 540 Alder Drive Milipitas, CA 85035
Re:
K993923 Radiation Therapy Planning System (RTP) Dated: February 18, 2000 Received: February 22, 2000 Regulatory Class: II 21 CFR 892.5050/Procode: 90 MUJ
Dear Ms. Brown:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalions for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce pror to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Dryg, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivaliation assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notfication submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for question and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/odrh/dsmamain.html".
Sincerely yours,
Daniel G. Schultz, M.D.
Captain, USPHS Director. Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
3
Page 1 of 1
510 (k) NUMBER (IF KNOWN): K993923
DEVICE NAME: Pinnacle3 RTP Software
INDICATIONS FOR USE:
Pinnacle3TM Radiation Therapy Planning Software is a computer software package intended to provide support for radiation therapy treatment planning for the treatment of benign or malignant disease processes.
Pinnacle3 Radiation Therapy Planning Software assists the clinician in formulating a treatment plan that maximizes the dose to the treatment volume while minimizing the dose to the surrounding normal tissues.
The device is indicated for use in patients deemed to be acceptable candidates for radiation treatment in the judgment of the clinician responsible for patient care.
Plans generated using this software are used in the determination of the course of a patient's radiation treatment. They are to be evaluated, modified and implemented by qualified medical personnel.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter-Use (Optional Format 1-2-96)
David C. Bryson
Division Sign-Off) Division of Reproductive, Abdominal, EN and Radiological D 510(k) Number
000020